Status:
COMPLETED
In Patients With Hip Dysplasia, Mid-Term Lower Extremities and Spine After Hip Arthroplasty Natural Course
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Total Hip Arthroplasty
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patients with developmental hip dysplasia often present to the outpatient clinic in adulthood with hip pain due to progressive hip osteoarthritis. However, they may have complaints such as limping, lu...
Detailed Description
Developmental hip dysplasia (DDH) describes the spectrum of anatomical changes in the acetabulum and proximal femur; these can cause limping, lower back pain, lumbar lordosis, and leg length variation...
Eligibility Criteria
Inclusion
- Patients with unilateral Crowe type 3 hip dysplasia
- Patients with unilateral Crowe type 4 hip dysplasia
Exclusion
- Patients with unilateral Crowe type 1 hip dysplasia
- Patients with unilateral Crowe type 2 hip dysplasia
- History of previous surgery on the hip for which surgery is planned
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06176612
Start Date
April 15 2021
End Date
October 1 2024
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakıf University
Istanbul, Fatih, Turkey (Türkiye), 34093